COMP <GO>
HROW vs UNH // RETURN ON INVESTED CAPITAL (ROIC)
Harrow Inc. (NASDAQ) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: HROW 3
— UNH 8
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: HROW
LAST: $29.99 (+2.04%) • MKT CAP: $1.12B
roic
42.90%
LAST: $410.91 (+0.94%) • MKT CAP: $368.83B
roic
11.47%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (HROW VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | HROW | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 75.10% | 88.57% | -13.47 | UNH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | 42.90% | 11.47% | +31.43 | HROW | /roic <GO> |
| EV/EBITDA & P/E Valuation | 33.6x | 16.4x | +17.15 | UNH | /valuation <GO> |
| Free Cash Flow Yield | 3.82% | 6.48% | -2.66 | UNH | /fcf-yield <GO> |
| Operating Margin | 11.20% | 4.82% | +6.38 | HROW | /operating-margins <GO> |
| Net Profit Margin | -1.90% | 3.14% | -5.04 | UNH | /net-margins <GO> |
| Revenue Growth (YoY) | 36.40% | 6.46% | +29.94 | HROW | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.28% | -2.28 | UNH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.67 | 3.12 | -0.45 | UNH | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 6.74% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 38.5 | 59.2 | -20.66 | UNH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.33 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 17.1x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.12B | $368.83B | -$367.71B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | HROW REV | UNH REV | HROW GROSS % | UNH GROSS % | HROW FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $272.3M | $447.57B | 75.1% | 88.7% | $43.0M | $16.07B |
| FY 2024 | $199.6M | $400.28B | 75.3% | 88.3% | -$23.8M | $20.70B |
| FY 2023 | $130.2M | $371.62B | — | 89.6% | $3.8M | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
HROW // BETA —
UNH // BETA 0.33